Compared to normal samples, HAGs with deletions displayed lower expressions in HCC (e.g., ANGPTL4 and TPI1), while HAGs with amplification might promote mRNA expressions (e.g., MRPS17 and NDRG1). This evidence concerns the gene ANGPTL4 and hepatocellular carcinoma.